Defence Therapeutics Financial Overview
Defence Therapeutics's market cap is currently $31.02M. The company's EPS TTM is $; its P/E ratio is -11.18; Defence Therapeutics is scheduled to report earnings on November 27, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.